南突尼斯系统性硬化症患者的HLA多态:一个病例对照研究
Aida Charfi1, Raida Ben Salah2, Olfa Frikha3
1Histocompatibility Department, Hedi Chaker UH, University of Sfax, Sfax, Tunisia.
Clinical rheumatology
|September 10, 2025
概括
突尼斯南部的系统性硬化症 (SSc) 易感性与特定的人类白血球抗原 (HLA) 基因相关. 在这个人群中,HLA-DRB1*11,DQB1*03:01和B53等位基因与增加的SSc风险有关.
科学领域:
- 免疫遗传学 免疫遗传学
- 类风湿病学 类风湿病学
- 人类遗传学 人类遗传学
背景情况:
- 系统性硬化症 (SSc) 是一种复杂的自身免疫性疾病,疑似具有遗传基础.
- 人类白细胞抗原 (HLA) 的关联,特别是与HLAII类的关联,涉及到各种人群中的SSc病原体.
- 之前没有任何研究研究了南突尼斯SSc患者的HLA概况.
研究的目的:
- 调查在突尼斯南部被诊断患有系统性硬化症 (SSc) 的患者中的人类白细胞抗原 (HLA) 概况.
- 在这个未研究的人群中,确定与SSc遗传敏感性相关的特定HLA等位基因.
主要方法:
- 采用了病例控制研究设计,涉及19名SSc患者和123名健康对照.
- 在HLA类I (HLA-A,HLA-B) 和类II (HLA-DRB1,HLA-DQB1) 中,采用微淋巴细胞毒性补充依赖和聚合酶连锁反应序列特异性原料 (PCR-SSP) 技术进行类型化.
- 使用SPSS软件和R语言进行统计分析,以进行可靠的数据解释.
主要成果:
- 该研究发现了SSc和特定的HLA等位基因之间的显著关联:HLA-DRB1*11 (pc=0.005),HLA-DQB1*03:01 (pc=0.002) 和HLA-B53 (pc=0.01).
- 发现HLA-B53关联是独立于HLA-DRB1*11.
- 在SSc患者和对照人群之间观察到B53-DRB1*11单元型分布的高度显著差异 (13.15%与0.8%,p <1.33x10^-5).
结论:
- 在突尼斯南部,系统性硬化症 (SSc) 与HLA-DRB1*11和HLA-DQB1*03:01等位基因相关.
- 阳性HLA-B53状态表明该队列中对SSc的敏感性增加.
- 需要进一步的研究来阐明这些HLA基因和SSc病原体之间的复杂关联.
关键词:
扩散性系统性硬化症 扩散性系统性硬化症易患疾病的易感性哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈有限系统性硬化症有限系统性硬化症 系统性硬化症更多相关视频
08:07Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
10.6K
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
13.4K
相关概念视频
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
